Published on 16/02/2017 5:28:12 PM | Source: Angel Broking Pvt Ltd

We maintain our NEUTRAL rating on Cadila Healthcare Ltd By Ms. Sarabjit Kour Nangra - Angel

Below is the views on  Cadila Healthcare Ltd  By Ms. Sarabjit Kour Nangra (VP Research- Pharma, Angel Broking Pvt Ltd)

“Cadila Healthcare did not got any 483’s issued in favour of its Moriaya plant. This marks an important relief for the company, Moriaya plant is a significant contributor to the overall sales of the company and has around 74 pending approvals, of the > 200 ANDA’s pending approval ( at the company level). Though after the approval the plant will take time to get approvals for its ANDA’s from this plant and hence will have a long term positive impact on the company. Though we view the news as positive , we maintain our NEUTRAL rating on the stock, given the valuations.” 


Click here to open demat account   

For More Angel Broking Pvt Ltd Disclaimer        

Above views are of the author and not of the website kindly read disclaimer